You are asking yourself 1000 questions about the fact that Acadia despite being approved Trofinetide does not go up (or rather goes down), the answer is only one, Acadia has to spend to sell and in a US bear market it follows the suffering XBI index, look at the trend of BLUE, CTIC, CDTX, AMLX, TVTX etc etc. all with approved drugs, they are all suffering, let's add the extra cash that Acadia has to give us this year, it is also strange that they have not made an offer on this as almost all of them have done post approval
Acadia, page-241
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.80 |
Change
-0.830(5.31%) |
Mkt cap ! $1.891B | |||
| Open | High | Low | Value | Volume |
| $15.65 | $15.72 | $14.76 | $11.61M | 772.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1392 | $14.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.90 | 1553 | 2 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |